Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Guifan Li"'
Autor:
Rong Tang, Guifan Li, Chengfu Zhang, Hengkui Zhi, Jiahong Zhu, Jianjun Wang, Qi Liang, Yuemei Hu, Changgui Li
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 16, Iss 11, Pp 2641-2648 (2020)
This phase Ⅱ, randomized, controlled trial aimed to evaluate the safety and immunogenicity of a various Sabin IPV preparations. Six hundred infants aged 60 ~ 90 days received one of five different vaccines: low- (group A), medium- (group B) or high
Externí odkaz:
https://doaj.org/article/44da982d72d74e018d7e26b74175e17e
Publikováno v:
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-8 (2020)
Abstract Background Maternal poliovirus antibodies could provide passive immunity to the newborns from poliovirus infection during their first few months of life, but they may impair the immune responses of infants to the poliovirus vaccine as well.
Externí odkaz:
https://doaj.org/article/60da1b63e24044bb80f3c35e046dd241
Autor:
Yuanyuan Wang, Fanyu Meng, Jingxin Li, Guifan Li, Jialei Hu, Jiaqian Cao, Qiufan Yu, Qi Liang, Fengcai Zhu
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 16, Iss 7, Pp 1579-1585 (2020)
Enterovirus 71 (EV71) is the dominant pathogen in severe and fatal hand–foot–mouth disease (HFMD) cases. Since 2015, three inactivated EV71 vaccines have been approved in China. The vaccination coverage of the EV71 vaccine has been relatively low
Externí odkaz:
https://doaj.org/article/c49bf96208ab49e2ae05ffc4e0584d59
Autor:
Wenjuan Wang, Qi Liang, Jiahong Zhu, Junxia Zhang, Junsheng Chen, Sulan Xie, Yuemei Hu, Guifan Li
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 1 (2022)
This study aimed to evaluate the immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine (PCV13). In total, 1200 infants were randomized into two groups with a 1:1 allocation and received a three-dose series of tested PCV13 or control
Externí odkaz:
https://doaj.org/article/66eee10851ce4c49875410ebf5d9bbf5
Autor:
Jiankai Liu, Baoying Huang, Guifan Li, Tao Huang, Danni Wang, Li Zhang, Yao Deng, Xianyun Chang, Yafei Liu, Weiqi Li, Siyuan Zhang, Weijin Huang, WenJie Tan, Lidong Gao
Publikováno v:
Pediatric Infectious Disease Journal; Dec2023, Vol. 42 Issue 12, p1136-1142, 7p
Autor:
Jiankai, Liu, Baoying, Huang, Guifan, Li, Xianyun, Chang, Yafei, Liu, Kai, Chu, Jialei, Hu, Yao, Deng, Dandan, Zhu, Jingliang, Wu, Li, Zhang, Meng, Wang, Weijin, Huang, Hongxing, Pan, Wenjie, Tan
Publikováno v:
The Journal of Infectious Diseases
Background Control of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic needs effective vaccines. Methods In a phase 2 randomized, double-blind, placebo-controlled trial, 500 adults aged 18–59 years or ≥60 years were randomize
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44668586fe77abf53f54c5427f7b6ea1
https://doi.org/10.1093/infdis/jiab627
https://doi.org/10.1093/infdis/jiab627
Autor:
Jingxin Li, Yuanyuan Wang, Guifan Li, Jiaqian Cao, Jialei Hu, Fengcai Zhu, Qiufan Yu, Fanyu Meng, Qi Liang
Publikováno v:
Hum Vaccin Immunother
Enterovirus 71 (EV71) is the dominant pathogen in severe and fatal hand-foot-mouth disease (HFMD) cases. Since 2015, three inactivated EV71 vaccines have been approved in China. The vaccination coverage of the EV71 vaccine has been relatively low, es
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5acedcf24b5f310df438a585e371aa93
https://doi.org/10.1080/21645515.2020.1737465
https://doi.org/10.1080/21645515.2020.1737465
Publikováno v:
Vaccine. 39(47)
Background Pneumococcus lead to various kinds of invasive disease such as pneumonia, otitis media, meningitis, bacteremia and so on. It has been a great threat to children under 5. A new 13-valent pneumococcal conjugate vaccine (PCV13) with carrier t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62b1f50dd4b1ab8a52f40d31838defec
https://pubmed.ncbi.nlm.nih.gov/34706841
https://pubmed.ncbi.nlm.nih.gov/34706841
Publikováno v:
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-8 (2020)
BMC Infectious Diseases
BMC Infectious Diseases
Background Maternal poliovirus antibodies could provide passive immunity to the newborns from poliovirus infection during their first few months of life, but they may impair the immune responses of infants to the poliovirus vaccine as well. In our st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6a1131d8bacd5a8732ad1ef219c98db
https://doi.org/10.1186/s12879-020-05348-1
https://doi.org/10.1186/s12879-020-05348-1
Autor:
Changgui Li, Rong Tang, Guifan Li, Yuemei Hu, Jiahong Zhu, Qi Liang, Chengfu Zhang, Hengkui Zhi, Jianjun Wang
Publikováno v:
Hum Vaccin Immunother
This phase Ⅱ, randomized, controlled trial aimed to evaluate the safety and immunogenicity of a various Sabin IPV preparations. Six hundred infants aged 60 ~ 90 days received one of five different vaccines: low- (group A), medium- (group B) or high
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::503832402256458a7fff6ca82a9f2368
https://pubmed.ncbi.nlm.nih.gov/32347778
https://pubmed.ncbi.nlm.nih.gov/32347778